The Japan Advantage: From Introduction to Action - Advancing Global Drug Development with Japan

​October 29, 2026

​Registration: 2:00 PM   |   Session: 2:30–6:00 PM

​LabCentral, 700 Main St, Cambridge, MA

​Join ENSEMBLExJ, a platform supporting global biotech companies seeking to enter and grow in Japan.

Hear from National Cancer Center Japan (NCCJ), Pharmaceuticals and Medical Devices Agency (PMDA), Japan Agency for Medical Research and Development (AMED), venture capital, global pharma, and startups on Japan’s drug development ecosystem, including:

▪ ENSEMBLExJ: Latest activities and opportunities
▪ PMDA: Regulatory programs and support for drug development
▪ AMED: Funding and collaboration opportunities
▪ VC, Pharma & Startups: Perspectives on Japan’s biotech ecosystem

​Connect with key players and explore opportunities in Japan.

We look forward to seeing you there!

​Learn more▼

​https://docs.google.com/document/d/1-0JyhCEo8NwnmCfiGyKyBWrmzQW35WpDDAjSwmE9RZ4/edit?usp=sharing